Suchergebnisse - "Akkerman, Onno"

Update of drug-resistant tuberculosis treatment guidelines: A turning point von Vanino, Elisa, Granozzi, Bianca, Akkerman, Onno W., Munoz-Torrico, Marcela, Palmieri, Fabrizio, Seaworth, Barbara, Tiberi, Simon, Tadolini, Marina

“… •A guideline update regarding drug-resistant tuberculosis (DR-TB) treatment has been recently published by World Health Organization.•6-month bedaquiline, …”
Volltext

Endobronchial tuberculosis von Eskandari, Siawosh K, Akkerman, Onno W

Volltext

Sensitivity and specificity of an electronic nose in diagnosing pulmonary tuberculosis among patients with suspected tuberculosis von Saktiawati, Antonia M. I., Stienstra, Ymkje, Subronto, Yanri W., Rintiswati, Ning, Sumardi, Gerritsen, Jan-Willem, Oord, Henny, Akkerman, Onno W., van der Werf, Tjip S.

“… To investigate the potency of a hand-held point-of-care electronic-nose to diagnose pulmonary tuberculosis (PTB) among those suspected of PTB. Setting: Lung …”
Volltext

Destroyed left lung due to multidrug-resistant Mycobacterium tuberculosis von Eskandari, Siawosh K, Akkerman, Onno W

Volltext

WHO online guide on the use of digital technologies for tuberculosis programmes von Akkerman, Onno W, Falzon, Dennis, Migliori, Giovanni Battista, Konstantynovska, Olha, Eyuboglu, Fusun Oner, Sismanidis, Charalambos, Kanchar, Avinash, Duarte, Raquel

Weitere Angaben

Post-tuberculosis treatment paradoxical reactions von Hermans, Sabine M., Akkerman, Onno W., Meintjes, Graeme, Grobusch, Martin P.

“… Paradoxical reactions (PR) to tuberculosis (TB) treatment are common during treatment, but have also been described after treatment. A presentation with …”
Volltext

Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment von Bolhuis, Mathieu S, Akkerman, Onno W, Sturkenboom, Marieke G G, Ghimire, Samiksha, Srivastava, Shashikant, Gumbo, Tawanda, Alffenaar, Jan-Willem C

“… Linezolid has been successfully used for treatment of multidrug-resistant tuberculosis (MDR-TB). However, dose- and duration-related toxicity limit its use …”
Weitere Angaben

Quantification of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor and their active metabolites in plasma using UHPLC-MS/MS: Doors open to the application of therapeutic drug monitoring in cystic fibrosis treatment von Wessels, A. Mireille A., Elzinga, Femke A., Koppelman, Gerard H., Akkerman, Onno W., Mian, Paola, Touw, Daan J.

“… An ultra-high performance liquid chromatography-tandem mass spectrometry method was developed to quantify the cystic fibrosis transmembrane conductance …”
Volltext

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study von Henriette Zweijpfenning, Sanne Maria, Chiron, Raphael, Essink, Sharon, Schildkraut, Jodie, Akkerman, Onno W, Aliberti, Stefano, Altenburg, Josje, Arets, Bert, van Braeckel, Eva, Delaere, Bénédicte, Gohy, Sophie, Haarman, Eric, Lorent, Natalie, McKew, Genevieve, Morgan, Lucy, Wagner, Dirk, van Ingen, Jakko, Hoefsloot, Wouter

Weitere Angaben

The agreement between bronchoalveolar lavage, bronchial wash and sputum culture: a retrospective study von Post, Anne-Eva, Bathoorn, Erik, Postma, Douwe F., Slebos, Dirk-Jan, Akkerman, Onno W.

“… Purpose Bronchoalveolar lavage is commonly used in clinical practice for unresolved pneumonia. However, bronchoalveolar lavage is not suitable for all patients …”
Volltext

Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in the Netherlands von Gafar, Fajri, Van't Boveneind-Vrubleuskaya, Natasha, Akkerman, Onno W, Wilffert, Bob, Alffenaar, Jan-Willem C

“… As a vulnerable population, children and adolescents with tuberculosis (TB) are faced with many challenges, even those who live in low TB incidence countries …”
Weitere Angaben

The pharmacokinetics of antibiotics in cystic fibrosis von Akkerman-Nijland, Anne M., Akkerman, Onno W., Grasmeijer, Floris, Hagedoorn, Paul, Frijlink, Henderik. W., Rottier, Bart. L., Koppelman, Gerard. H., Touw, Daniel. J.

“… Dosing of antibiotics in people with cystic fibrosis (CF) is challenging, due to altered pharmacokinetics, difficulty of lung tissue penetration, and …”
Volltext

Precision and personalized medicine and anti-TB treatment: Is TDM feasible for programmatic use? von Alffenaar, Jan-Willem C., Akkerman, Onno W., Kim, Hannah Yejin, Tiberi, Simon, Migliori, Giovanni Battista

“… Therapeutic Drug Monitoring (TDM) is increasingly recommended to ensure the correct drug dose thereby minimizing adverse events and maximizing regimen …”
Volltext

Pharmacokinetics of Ivacaftor, Tezacaftor, Elexacaftor, and Lumacaftor in Special Cystic Fibrosis Populations: A Systematic Review von Elzinga, Femke A., Malik, Paul R. V., Akkerman, Onno W., Rottier, Bart L., van der Vaart, Hester, Touw, Daan J., Koppelman, Gerard H., Mian, Paola

“… Following the development of cystic fibrosis transmembrane conductance regulator (CFTR) modulators (ivacaftor, tezacaftor, elexacaftor, and lumacaftor), the …”
Volltext

Strategies to Enhance Diagnostic Capabilities for the New Drug-Resistant Tuberculosis (DR-TB) Drugs von Saktiawati, Antonia Morita Iswari, Vasiliu, Anca, Saluzzo, Francesca, Akkerman, Onno W.

“… The global burden of drug-resistant tuberculosis (DR-TB) continues to challenge healthcare systems worldwide. There is a critical need to tackle DR-TB by …”
Volltext

Viewpoint on WHO implementation guidance on tuberculosis infection prevention and control von Akkerman, Onno W, Migliori, Giovanni Battista, Falzon, Dennis, Garcia-Basteiro, Alberto L, Kanchar, Avinash, Konstantynovska, Olha, Eyuboglu, Fusun Oner, Duarte, Raquel

Weitere Angaben

Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis von Vogensen, Vanessa B, Singh, Sanjay, Allende, Christopher J, Engelthaler, David M, Boorgula, Gunavanthi D, Thomas, Tania A, Sturkenboom, Marieke G G, Akkerman, Onno W, Gumbo, Tawanda, Srivastava, Shashikant

“… The impact of heteroresistance on tuberculosis (TB) treatment outcomes is unclear, as is the role of different rifampin and isoniazid exposures on developing …”
Weitere Angaben

Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment von Sturkenboom, Marieke G G, Simbar, Noviana, Akkerman, Onno W, Ghimire, Samiksha, Bolhuis, Mathieu S, Alffenaar, Jan-Willem C

“… Amikacin has been used for over 40 years in multidrug resistant tuberculosis (MDR-TB), but there is still debate on the right dose. The aim of this review was …”
Weitere Angaben

High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015 von Ravensbergen, Sofanne J., Lokate, Mariëtte, Cornish, Darren, Kloeze, Eveline, Ott, Alewijn, Friedrich, Alex W., van Hest, Rob, Akkerman, Onno W., de Lange, Wiel C., van der Werf, Tjip S., Bathoorn, Erik, Stienstra, Ymkje

“… The current refugee crisis emphasizes the need for information on infectious diseases and resistant microorganisms in asylum seekers with possible consequences …”
Volltext

Combining digital adherence technology and therapeutic drug monitoring for personalised tuberculosis care von Ghimire, Samiksha, Iskandar, Deni, van der Borg-Boekhout, Roelina, Zenina, Marina, Bolhuis, Mathieu S, Kerstjens, Huib A M, van Rossum, Marieke, Touw, Daan J, Zijp, Tanja R, van Boven, Job F M, Akkerman, Onno W

Weitere Angaben